[EN] INHIBITORS OF LEUCINE RICH REPEAT KINASE 2<br/>[FR] INHIBITEURS DE LA KINASE 2 À RÉPÉTITION RICHE EN LEUCINE
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2019012093A1
公开(公告)日:2019-01-17
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, to processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases associated with or characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).
本发明涉及抑制LRRK2激酶活性的新化合物,以及它们的制备方法、含有它们的组合物,以及它们在治疗或预防与LRRK2激酶活性相关或以其为特征的疾病中的应用,例如帕金森病、阿尔茨海默病和肌萎缩侧索硬化症(ALS)。